PHARMACEUTICAL CARE FOR PERSONES WITH MIGRAINE: WAYS TO IMPROVE THE EFFICACY AND SAFETY OF THERAPY
DOI:
https://doi.org/10.11603/2312-0967.2025.1.15170Keywords:
migraine, pharmaceutical care, nonprescription and prescription medicines, efficacy and safety of the therapyAbstract
The aim of the work. Identify the role of the patient/pharmacy visitor, physician/pharmacist in the implementation of pharmaceutical care in the treatment of migraine.
Materials and Methods. The methodological basis of the study is based on the principles of objectivity and systematicity. The study used a set of general scientific and special methods: theoretical, method of generalization, data systematization, comparison, analysis, and questionnaire. A questionnaire survey was conducted among 20 pharmacy visitors who visited the pharmacy to purchase a drug for the treatment of migraine.
Results and Discussion. For mild to moderate attacks, our respondents used simple analgesics and NSAIDs (ibuprofen, paracetamol, naproxen, and acetylsalicylic acid). The choice of medications for symptomatic treatment was based on the principles of responsible self-medication with the advisory participation of a pharmacist. For severe seizures, triptans were used: sumatriptan, zolmitriptan, and risatriptan, which were prescribed by a doctor. Out of 20 respondents, only 3 received preventive treatment, which is 15%. The medications used by respondents for preventive treatment were: propranolol (10 mg tablets); metoprolol (25 mg film-coated slow-release tablets) and topiramate (25 mg film-coated tablets). As for dosage forms, the most popular were tablets and capsules. The majority of respondents (90%) preferred them when choosing a dosage form. Only 2 respondents (10%) preferred nasal spray. Regarding the rules for taking medications for migraine treatment/prevention: 16 respondents (80%) adhere to the rules of taking medications, and only 4 respondents (20%) did not attach due importance to the conditions of rational use of medications. Among the factors influencing treatment adherence, respondents mentioned: convenient dosage form, rapid onset of action, effect duration, minimal need for repeat dose, and the possibility of self-medication.
Conclusions. Pharmaceutical care (at all stages of its implementation) plays an important role in improving the efficacy and safety of migraine therapy. It is the interaction of medical and pharmaceutical professionals and a high degree of involvement of persons with migraine in the process that will help prevent attacks, reduce the frequency and severity of headaches, and improve quality of life. Improvement of pharmaceutical care in the treatment of migraine should be continuous, taking into account the latest medical technologies and the development of knowledge in neurology.
References
Pescador Ruschel MA, De Jesus O., editors. Migraine Headache [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/32809622/.
Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022;12:800605. DOI: 10.3389/fneur.2021.800605. DOI: https://doi.org/10.3389/fneur.2021.800605
Mungoven TJ, Henderson LA, Meylakh N. Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives. Front Pain Res (Lausanne). 2021;2:705276. DOI: 10.3389/fpain.2021.705276. DOI: https://doi.org/10.3389/fpain.2021.705276
Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z; Lifting The Burden: the Global Campaign against Headache. Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. DOI: 10.1186/s10194-020-01208-0. DOI: https://doi.org/10.1186/s10194-020-01208-0
Tzankova V, Becker WJ, Chan TLH. Diagnosis and acute management of migraine. CMAJ. 2023;195(4):E153-58. DOI: 10.1503/cmaj.211969. DOI: https://doi.org/10.1503/cmaj.211969
Jenkins B. Migraine management. Aust Prescr. 2020;43(5):148-51. DOI: 10.18773/austprescr.2020.047. DOI: https://doi.org/10.18773/austprescr.2020.047
Eller M, Cheng S. Migraine management: an update for the 2020s. Intern Med J. 2022;52(7):1123-28. DOI: 10.1111/imj.15843. DOI: https://doi.org/10.1111/imj.15843
Athavale A, Athavale T, Roberts DM. Antiemetic drugs: what to prescribe and when. Aust Prescr. 2020;43(2):49-56. DOI: 10.18773/austprescr.2020.011. DOI: https://doi.org/10.18773/austprescr.2020.011
Kompendium. Likarski prepаrati [Internet]. Available from: https://compendium.com.ua/uk/
Indrayan A, Malhotra KR. Medical biostatistics. 4th ed. Boca Raton: CRC Press; 2018. 685 p. https://doi.org/10.4324/9781315100265 DOI: https://doi.org/10.4324/9781315100265
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
